BridgeMD
New treatment option for Macrosomia, Fetal
Official title New Markers of Glycation to Predict Gestational Diabetes Mellitus and Macrosomia.
ClinicalTrials.gov ID: NCT06048510
What this study is testing
- What it's testing
- Gestational diabetes mellitus (GDM) increases the risk of macrosomia and other adverse pregnancy outcomes. Screening strategies are debated: universal vs.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 99
You may be able to join if
- Age ≥ 18 years
- Singleton pregnancy (or twin pregnancy reduced spontaneously or medically before 14 weeks of amenorrhea)
- Gestational age at inclusion \<28 weeks of amenorrhea
- Participant affiliated with or beneficiary of a social security scheme
- Collection of patient consent.
You likely can't join if
- Gestational age at inclusion ≥ 28 weeks of amenorrhea
- Multiple pregnancy
- Known diabetes prior to pregnancy
- History of bariatric surgery
- Expected delivery in another maternity unit not participating in the study
- Person deprived of liberty by judicial or administrative decision
See the full eligibility criteria
- Age ≥ 18 years
- Singleton pregnancy (or twin pregnancy reduced spontaneously or medically before 14 weeks of amenorrhea)
- Gestational age at inclusion \<28 weeks of amenorrhea
- Participant affiliated with or beneficiary of a social security scheme
- Collection of patient consent.
- Gestational age at inclusion ≥ 28 weeks of amenorrhea
- Multiple pregnancy
- Known diabetes prior to pregnancy
- History of bariatric surgery
- Expected delivery in another maternity unit not participating in the study
- Person deprived of liberty by judicial or administrative decision
- Guardianship or curatorship
- Participant not affiliated or not benefiting from a social security scheme.
The study team makes the final eligibility decision.
Where it's taking place
- Bordeaux, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bordeaux, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.